查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451703

2024-2032 年按產品類型、活性成分、最終用戶和地區分類的睾酮替代療法市場報告

Testosterone Replacement Therapy Market Report by Product Type, Active Ingredients, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球睪固酮替代療法市場規模達到20億美元。展望未來， IMARC Group預計到2032年市場規模將達到27億美元，2024-2032年複合年成長率（CAGR）為3.4%。大眾性腺功能減退症盛行率不斷上升，新配方、給藥方法和治療方案的不斷開發，以及全球醫療基礎設施的持續改進是推動市場的一些主要因素。

睪固酮替代療法 (TRT) 是一種旨在解決個人（尤其是男性）睪固酮水平低下問題的醫療方法。睪酮是一種主要負責男性性特徵的發育和維持以及整體健康的荷爾蒙。 TRT涉及施用外源性睪固酮來補充身體的自然產生，旨在將睪固酮水平恢復到正常範圍內。低睪酮水平會導致各種症狀，包括性慾降低、疲勞、肌肉損失、情緒變化和骨密度降低。 TRT 可以緩解睪酮缺乏症患者的這些症狀並改善其整體生活品質。此療法可透過多種方法進行，包括注射、貼片、凝膠或植入皮下的顆粒。

性腺功能減退症盛行率的上升正在推動全球市場的發展。此外，配方和遞送方法的不斷進步，包括更新的遞送方法，如經皮貼片、凝膠、皮下植入物和口腔系統，提供了更高的便利性和功效，提高了患者的依從性和滿意度，從而推動了市場的發展。此外，文化接受度、恥辱感的減少以及對 TRT 益處的更廣泛理解也促進了市場的成長。此外，各種製藥公司正在投資開發新的配方、給藥方法和改進的治療方案，這推動了市場的成長。除此之外，在醫療基礎設施不斷完善、醫療服務可近性提高以及可支配收入增加等因素的推動下，醫療支出的整體成長促進了TRT市場的擴張。

睾酮替代療法市場趨勢/促進因素：

人口老化和睪固酮缺乏症的盛行率日益增加

人口老化是睾酮替代療法（TRT）的重要市場驅動力。隨著男性年齡的成長，他們的天然睪固酮生成量往往會下降，從而導致與睪固酮缺乏相關的症狀。隨著全球人口老化，睪固酮缺乏症的盛行率越來越高。同時，人們對 TRT 的症狀和益處的認知不斷增強，這增加了對睪固酮替代產品和服務的需求。此外，醫療保健提供者發現越來越多的老年患者尋求睪固酮水平低下的治療，以緩解症狀，例如精力不足、性功能下降和肌肉損失，從而推動 TRT 市場的成長。

對睪酮缺乏症的認知和診斷不斷提高

近年來，人們對睾酮缺乏症的認知和診斷顯著增加。醫療保健專業人員對低睪酮水平的症狀和影響越來越了解，從而改善檢測和診斷。此外，製藥公司和醫療保健組織的教育活動和行銷工作也有助於提高大眾對 TRT 等治療方案可用性的認知。這些措施強調了 TRT 在解決與睪固酮缺乏相關的身體和心理症狀方面的潛在益處。因此，越來越多的人尋求醫療建議並接受診斷，導致 TRT 的患者群體更大。這種認知和診斷的提高導致了睾酮替代療法市場的擴大。

越來越關注男性健康

人們越來越重視男性的健康和保健，包括身體、心理和性福祉。男性變得更加積極主動地尋求解決與年齡相關的問題，包括睪固酮缺乏。隨著社會態度轉向消除男性健康問題的污名化，個人更願意討論和尋求與睪固酮失衡相關的疾病的治療。這種文化轉變，加上透過網路和社群媒體獲取醫療保健資訊的機會增加，導致對 TRT 的需求更大。市面上越來越多的男性積極尋求治療方法來解決睪固酮缺乏症並提高整體生活品質。此外，不斷擴大的健康產業和男性醫療保健整體方法的整合進一步刺激了對 TRT 的需求。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球睪酮替代療法市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品類型

  • 口腔植體
    • 市場走向
    • 市場預測
  • 注射
    • 市場走向
    • 市場預測
  • 補丁
    • 市場走向
    • 市場預測
  • 乳霜/凝膠
    • 市場走向
    • 市場預測
  • 牙齦/頰黏膠
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依活性成分

  • 睪固酮
    • 市場走向
    • 市場預測
  • 甲基睪酮
    • 市場走向
    • 市場預測
  • 環丙酸睪酮
    • 市場走向
    • 市場預測
  • 十一酸睪酮
    • 市場走向
    • 市場預測
  • 庚酸睪酮
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 居家護理
    • 市場走向
    • 市場預測
  • 專科診所
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AbbVie Inc.
    • Acerus Pharmaceuticals Corporation
    • Antares Pharma Inc. (Halozyme Therapeutics)
    • Clarus Therapeutics Inc.
    • Endo International plc
    • Ferring Pharmaceuticals
    • Kyowa Kirin Co. Ltd.
    • Lupin Limited
    • Pfizer Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.)
    • Upsher-Smith Laboratories LLC (Sawai Pharmaceutical Co. Ltd.)
Product Code: SR112024A6832

The global testosterone replacement therapy market size reached US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.7 Billion by 2032, exhibiting a growth rate (CAGR) of 3.4% during 2024-2032. The rising prevalence of hypogonadism among the masses, continual development of new formulations, delivery methods, and improved treatment protocols, and ongoing improvements in healthcare infrastructure across the globe are some of the major factors propelling the market.

Testosterone replacement therapy (TRT) is a medical treatment designed to address low testosterone levels in individuals, particularly men. Testosterone is a hormone primarily responsible for the development and maintenance of male sexual characteristics and overall well-being. TRT involves the administration of exogenous testosterone to supplement the body's natural production, aiming to restore testosterone levels within the normal range. Low testosterone levels can result in various symptoms, including reduced libido, fatigue, muscle loss, mood changes, and decreased bone density. TRT can alleviate these symptoms and improve the overall quality of life for individuals experiencing testosterone deficiency. The therapy can be administered through various methods, including injections, patches, gels, or pellets implanted under the skin.

The rising prevalence of hypogonadism is driving the global market. Moreover, continual advancements in the formulation and delivery methods, including newer delivery methods, such as transdermal patches, gels, subcutaneous implants, and buccal systems, offer improved convenience and efficacy, enhancing patient compliance and satisfaction is providing a boost to the market. Furthermore, cultural acceptance, reduced stigma, and a broader understanding of the benefits of TRT have contributed to the growth of the market. Also, various pharmaceutical companies are investing in the development of new formulations, delivery methods, and improved treatment protocols, which fuels the growth of the market. Apart from this, the overall growth in healthcare expenditure, driven by factors such as rising healthcare infrastructure, improving access to healthcare services, and increasing disposable income, has catalyzed the expansion of the TRT market.

Testosterone Replacement Therapy Market Trends/Drivers:

Aging Population and the Increasing Prevalence Of Testosterone Deficiency

The aging population is a significant market driver for testosterone replacement therapy (TRT). As men age, their natural testosterone production tends to decline, resulting in symptoms associated with testosterone deficiency. With the global population experiencing a demographic shift towards an older age bracket, there is a growing prevalence of testosterone deficiency. Coupled with this, the increasing awareness of the symptoms and benefits of TRT, is augmenting the demand for testosterone replacement products and services. Furthermore, healthcare providers are witnessing an increase in older patients seeking treatment for low testosterone levels to alleviate symptoms, such as reduced energy, diminished sexual function, and muscle loss, thereby propelling the growth of the TRT market.

Rising Awareness and Diagnosis of Testosterone Deficiency

There has been a notable increase in awareness and diagnosis of testosterone deficiency in recent years. Healthcare professionals are becoming more knowledgeable about the symptoms and effects of low testosterone levels, leading to improved detection and diagnosis. Additionally, educational campaigns and marketing efforts by pharmaceutical companies and healthcare organizations have contributed to raising public awareness about the availability of treatment options, such as TRT. These initiatives emphasize the potential benefits of TRT in addressing the physical and psychological symptoms associated with testosterone deficiency. As a result, more individuals are seeking medical advice and getting diagnosed, leading to a larger patient pool for TRT. This heightened awareness and diagnosis have resulted in an expanded market for testosterone replacement therapies.

Growing Focus on Men's Health and Wellness

There is a growing emphasis on men's health and wellness, encompassing physical, mental, and sexual well-being. Men are becoming more proactive in seeking solutions to age-related issues, including testosterone deficiency. As societal attitudes shift towards destigmatizing men's health concerns, individuals are more open to discussing and seeking treatment for conditions related to testosterone imbalance. This cultural shift, along with increased accessibility to healthcare information through the internet and social media, has contributed to a greater demand for TRT. The market is witnessing a rise in men who are actively pursuing therapies to address testosterone deficiency and improve their overall quality of life. Furthermore, the expanding wellness industry and the integration of holistic approaches in men's healthcare have further fueled the demand for TRT.

Testosterone Replacement Therapy Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global testosterone replacement therapy market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, active ingredients, and end user.

Breakup by Product Type:

Oral implants

Injections

Patches

Creams/Gels

Gums/Buccal Adhesives

Others

Injections dominate the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes oral implants, injections, patches, creams/gels, gums/buccal adhesives, and others. According to the report, injections represented the largest segment.

On the basis of product type, injections represent the largest product type segment in the testosterone replacement therapy (TRT) market. Injections are a popular and widely utilized method for delivering testosterone replacement. They offer several advantages, including reliable dosing, immediate effects, and the ability to closely monitor the administration. Injections typically involve intramuscular or subcutaneous delivery, ensuring efficient absorption of testosterone into the bloodstream. This method provides healthcare professionals with greater control over dosage and allows for adjustments based on individual patient needs. Moreover, they offer convenience as they are administered less frequently compared to other forms of TRT, such as transdermal patches or gels. This reduced frequency of administration contributes to better patient compliance. Additionally, injections are preferred in cases where patients require higher testosterone levels or have specific medical conditions that may necessitate precise dosing.

Breakup by Active Ingredients:

Testosterone

Methyl Testosterone

Testosterone Cypionate

Testosterone Undecanoate

Testosterone Enanthate

Testosterone holds the largest share in the market

A detailed breakup and analysis of the market based on the active ingredients has also been provided in the report. This includes testosterone, methyl testosterone, testosterone cypionate, testosterone undecanoate, and testosterone enanthate. According to the report, testosterone accounted for the largest market share.

Testosterone represents the largest segment in the testosterone replacement therapy (TRT) market. Testosterone is the primary hormone responsible for the development and maintenance of male sexual characteristics and overall well-being. In TRT, the goal is to supplement or replace the body's natural testosterone production, and testosterone is the most direct and commonly used active ingredient to achieve this. It is available in various formulations, including injections, transdermal patches, gels, and pellets. Moreover, it provides healthcare providers with the flexibility to tailor treatment regimens to individual patient needs. Additionally, testosterone-based products have been extensively studied and researched, providing a robust foundation of clinical evidence supporting their effectiveness in managing testosterone deficiency. Due to its central role in TRT and its proven efficacy, testosterone remains the dominant active ingredient segment in the TRT market, serving as the cornerstone for addressing testosterone imbalances and improving patients' quality of life.

Breakup by End User:

Hospitals

Homecare

Specialty Clinics

Others

Speciality Clinics hold the largest share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, homecare, specialty clinics, and others. According to the report, specialty clinics accounted for the largest market share.

On the basis of end user, specialty clinics represent the largest segment in the testosterone replacement therapy (TRT) market. Specialty clinics are healthcare facilities that focus on specific medical specialties or conditions, including men's health and hormone optimization. These clinics are staffed with specialized healthcare professionals, such as endocrinologists, urologists, and hormone therapy specialists, who possess in-depth knowledge and expertise in diagnosing and treating testosterone deficiency. They offer a dedicated and comprehensive approach to TRT, providing personalized care and tailored treatment plans for patients with low testosterone levels. These clinics often have the necessary resources and equipment to administer various forms of TRT, including injections, patches, gels, and pellets. Moreover, specialty clinics are equipped to conduct thorough evaluations, monitor hormone levels, and adjust treatment regimens as needed to optimize patient outcomes.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest testosterone replacement therapy market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

Region-wise, North America exhibits a clear dominance in the testosterone replacement therapy (TRT) market. The well-developed healthcare infrastructure in the region is characterized by advanced medical facilities, specialized clinics, and a strong network of healthcare providers. This infrastructure facilitates the diagnosis, treatment, and monitoring of testosterone deficiency, driving the demand for TRT. Additionally, the region has a high prevalence of testosterone deficiency, which can be attributed to factors such as an aging population, sedentary lifestyles, and increasing awareness of the symptoms and benefits of TRT. Moreover, the region is at the forefront of medical advancements and research in the field of hormone replacement therapies, leading to the availability of a wide range of TRT products and treatment options. Furthermore, robust regulatory frameworks and guidelines ensure the safety and efficacy of TRT in North America, instilling confidence in both healthcare providers and patients.

Competitive Landscape:

Companies are heavily investing in research and development activities to develop innovative TRT products and treatment options. This includes exploring new formulations, delivery systems, and technologies to enhance treatment efficacy, convenience, and patient compliance. Several leading players are conducting clinical trials to gather evidence supporting the safety and efficacy of their TRT products. These trials help validate the therapeutic benefits of their offerings and gain regulatory approvals. Moreover, companies engage in marketing and awareness campaigns to educate healthcare professionals and patients about the symptoms of testosterone deficiency and the benefits of TRT. These campaigns aim to increase awareness, reduce stigma, and drive demand for their products and services. Additionally, companies collaborate with healthcare providers, specialty clinics, and research institutions to expand their market reach, gain access to patient populations, and leverage expertise in specific therapeutic areas.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

AbbVie Inc.

Acerus Pharmaceuticals Corporation

Antares Pharma Inc. (Halozyme Therapeutics)

Clarus Therapeutics Inc

Endo International plc

Ferring Pharmaceuticals

Kyowa Kirin Co. Ltd.

Lupin Limited

Pfizer Inc.

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.)

Upsher-Smith Laboratories LLC (Sawai Pharmaceutical Co. Ltd.)

Recent Developments:

In May 2023, Lupin Limited announced a strategic collaboration with Enzene Biosciences to launch Cetuximab in India, the first biosimilar developed for Cetuximab. This collaboration marks a significant milestone in expanding therapeutic options and fostering innovation in the critical area of treatment of head and neck cancer.

In January 2023, Sun Pharmaceutical Industries Ltd. launches SEZABY (phenobarbital sodium) in the U.S. for Treatment of Neonatal Seizures. SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection.

In July 2022, Acerus Pharmaceuticals Corporation announces acquisition of serenity pharmaceuticals LLC and acquisition of global rights to Noctiva. The combined enterprise brings a broader array of offerings to the urology and men's health markets, leveraging the expanding footprint and strengthening the outlook for years.

Key Questions Answered in This Report:

  • How has the global testosterone replacement therapy market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global testosterone replacement therapy market?
  • What is the impact of each driver, restraint, and opportunity on the global testosterone replacement therapy market?
  • What are the key regional markets?
  • Which countries represent the most attractive testosterone replacement therapy market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the testosterone replacement therapy market?
  • What is the breakup of the market based on the active ingredients?
  • Which is the most attractive active ingredients in the testosterone replacement therapy market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the testosterone replacement therapy market?
  • What is the competitive structure of the global testosterone replacement therapy market?
  • Who are the key players/companies in the global testosterone replacement therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Testosterone Replacement Therapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Oral Implants
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Injections
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Patches
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Creams/Gels
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Gums/Buccal Adhesives
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Active Ingredients

  • 7.1 Testosterone
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Methyl Testosterone
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Testosterone Cypionate
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Testosterone Undecanoate
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Testosterone Enanthate
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Homecare
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Specialty Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Acerus Pharmaceuticals Corporation
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Antares Pharma Inc. (Halozyme Therapeutics)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 Clarus Therapeutics Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Endo International plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Ferring Pharmaceuticals
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Kyowa Kirin Co. Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Lupin Limited
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pfizer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sun Pharmaceutical Industries Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Upsher-Smith Laboratories LLC (Sawai Pharmaceutical Co. Ltd.)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Testosterone Replacement Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Testosterone Replacement Therapy Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Testosterone Replacement Therapy Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Testosterone Replacement Therapy Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Testosterone Replacement Therapy Market: Breakup by Active Ingredients (in %), 2023
  • Figure 6: Global: Testosterone Replacement Therapy Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Testosterone Replacement Therapy Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Testosterone Replacement Therapy (Oral Implants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Testosterone Replacement Therapy (Oral Implants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Testosterone Replacement Therapy (Injections) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Testosterone Replacement Therapy (Injections) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Testosterone Replacement Therapy (Patches) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Testosterone Replacement Therapy (Patches) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Testosterone Replacement Therapy (Creams/Gels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Testosterone Replacement Therapy (Creams/Gels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Testosterone Replacement Therapy (Gums/Buccal Adhesives) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Testosterone Replacement Therapy (Gums/Buccal Adhesives) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Testosterone Replacement Therapy (Other Product Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Testosterone Replacement Therapy (Other Product Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Testosterone Replacement Therapy (Testosterone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Testosterone Replacement Therapy (Testosterone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Testosterone Replacement Therapy (Methyl Testosterone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Testosterone Replacement Therapy (Methyl Testosterone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Testosterone Replacement Therapy (Testosterone Cypionate) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Testosterone Replacement Therapy (Testosterone Cypionate) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Testosterone Replacement Therapy (Testosterone Undecanoate) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Testosterone Replacement Therapy (Testosterone Undecanoate) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Testosterone Replacement Therapy (Testosterone Enanthate) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Testosterone Replacement Therapy (Testosterone Enanthate) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Testosterone Replacement Therapy (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Testosterone Replacement Therapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Testosterone Replacement Therapy (Homecare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Testosterone Replacement Therapy (Homecare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Testosterone Replacement Therapy (Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Testosterone Replacement Therapy (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Testosterone Replacement Therapy (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Testosterone Replacement Therapy (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: North America: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: North America: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: United States: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: United States: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Canada: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Canada: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Asia-Pacific: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Asia-Pacific: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: China: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: China: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Japan: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Japan: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: India: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: India: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: South Korea: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: South Korea: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Australia: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Australia: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Indonesia: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Indonesia: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Europe: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Europe: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Germany: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Germany: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: France: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: France: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: United Kingdom: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: United Kingdom: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Italy: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Italy: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Spain: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Spain: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Russia: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Russia: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Latin America: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Latin America: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Brazil: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Brazil: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Mexico: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Mexico: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Middle East and Africa: Testosterone Replacement Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Middle East and Africa: Testosterone Replacement Therapy Market: Breakup by Country (in %), 2023
  • Figure 86: Middle East and Africa: Testosterone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Global: Testosterone Replacement Therapy Industry: Drivers, Restraints, and Opportunities
  • Figure 88: Global: Testosterone Replacement Therapy Industry: Value Chain Analysis
  • Figure 89: Global: Testosterone Replacement Therapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Testosterone Replacement Therapy Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Testosterone Replacement Therapy Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Testosterone Replacement Therapy Market Forecast: Breakup by Active Ingredients (in Million US$), 2024-2032
  • Table 4: Global: Testosterone Replacement Therapy Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Testosterone Replacement Therapy Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Testosterone Replacement Therapy Market: Competitive Structure
  • Table 7: Global: Testosterone Replacement Therapy Market: Key Players